Incidence of radiodermatitis in breast cancer patients during hypofractionated radiotherapy.

OBJECTIVE: To analyze the incidence, dose of occurrence, grade, severity, and associated risk factors for the development of radiodermatitis, by area of the irradiated breast, in women with breast cancer, during hypofractionated radiotherapy. METHOD: Observational, prospective, and longitudinal study, according to the guidelines of the Strengthening the Reporting of Observational studies in Epidemiology, carried out between May 2019 and May 2021. RESULTS: A total of 104 women participated in the study, and 73.1% (95%CI: 64-82) developed signs of radiodermatitis during treatment. The majority (63.5%, 95%CI: 54-73) developed erythema in the axillary region with about 36.5 Grays. Women with large breasts and statin users are more likely to develop radiodermatitis. However, women with Phototype III skin color classification (light brown skin) are less likely to develop radiodermatitis, with skin color being a protective factor. CONCLUSION: The incidence of radiodermatitis in women with breast cancer during hypofractionated radiotherapy is significant. Therefore, the development of protocols for the management of this radiotoxicity is suggested, considering the cumulative dose and associated risk factors.

Incidence of radiodermatitis in breast cancer patients during hypofractionated radiotherapy / Incidencia de radiodermatitis en pacientes con cáncer de mama durante la radioterapia hipofraccionada / Incidência de radiodermatite em pacientes com câncer de mama durante a radioterapia hipofracionada

ABSTRACT Objective: To analyze the incidence, dose of occurrence, grade, severity, and associated risk factors for the development of radiodermatitis, by area of the irradiated breast, in women with breast cancer, during hypofractionated radiotherapy. Method: Observational, prospective, and longitudinal study, according to the guidelines of the Strengthening the Reporting of Observational studies in Epidemiology, carried out between May 2019 and May 2021. Results: A total of 104 women participated in the study, and 73.1% (95%CI: 64-82) developed signs of radiodermatitis during treatment. The majority (63.5%, 95%CI: 54-73) developed erythema in the axillary region with about 36.5 Grays. Women with large breasts and statin users are more likely to develop radiodermatitis. However, women with Phototype III skin color classification (light brown skin) are less likely to develop radiodermatitis, with skin color being a protective factor. Conclusion: The incidence of radiodermatitis in women with breast cancer during hypofractionated radiotherapy is significant. Therefore, the development of protocols for the management of this radiotoxicity is suggested, considering the cumulative dose and associated risk factors.

RESUMEN Objectivo: Analizar la incidencia, dosis de ocurrencia, grado, severidad y factores de riesgo asociados para el desarrollo de radiodermatitis, por área de la mama irradiada, en mujeres con cáncer de mama, durante radioterapia hipofraccionada. Método: Estudio observacional, prospectivo y longitudinal, según las directrices del Strengthening the Reporting of Observational studies in Epidemiology, realizado entre mayo de 2019 y mayo de 2021. Resultados: Participaron del estudio 104 mujeres, el 73,1% (IC 95%: 64-82) desarrollaron signos de radiodermatitis durante el tratamiento. La mayoría (63,5%, IC95%: 54-73) desarrolló eritema en la región axilar con alrededor de 36,5 Grays. Las mujeres con senos grandes y usuarias de estatinas tienen más probabilidades de desarrollar radiodermatitis. Sin embargo, las mujeres con color de piel clasificado como Fototipo III (piel morena clara) tienen menos probabilidades de desarrollar radiodermatitis, siendo el color de piel un factor protector. Conclusión: La incidencia de radiodermatitis en mujeres con cáncer de mama durante la radioterapia hipofraccionada es significativa. Por lo tanto, se sugiere el desarrollo de protocolos para el manejo de esta radiotoxicidad, considerando la dosis acumulada y los factores de riesgo asociados.

RESUMO Objetivo: Analisar a incidência, a dose de ocorrência, o grau, a severidade e os fatores de risco associados para o desenvolvimento de radiodermatite, por área da mama irradiada, em mulheres com câncer de mama, durante a radioterapia hipofracionada. Método: Estudo observacional, prospectivo e longitudinal, conforme diretrizes do Strengthening the Reporting of Observational studies in Epidemiology, realizado entre maio de 2019 e maio de 2021. Resultados: Participaram do estudo 104 mulheres, 73,1% (IC95%: 64-82) desenvolveram sinais de radiodermatite durante o tratamento. A maioria (63,5%, IC95%: 54-73) desenvolveu eritema na região axilar com cerca de 36,5 Grays. Mulheres com mamas volumosas e usuárias de estatinas possuem maior chance de desenvolver radiodermatite. Entretanto, mulheres com a cor da pele classificada como Fototipo III (pele morena clara) possuem menor chance de desenvolver radiodermatite, sendo a cor da pele um fator protetor. Conclusão A incidência de radiodermatite em mulheres com câncer de mama durante a radioterapia hipofracionada é expressiva. Sugere-se, portanto, o desenvolvimento de protocolos para o manejo desta radiotoxicidade, considerando a dose cumulativa e fatores de risco associados.

Clinicopathological analysis and survival outcomes of primary salivary gland tumors in pediatric patients: A systematic review.

BACKGROUND: Salivary gland tumors are a diverse group of uncommon neoplasms that are rare in pediatric patients. The aim of this study was to evaluate the clinicopathological profile and survival outcomes of pediatric patients affected by salivary gland tumors. MATERIALS AND METHODS: An extensive search was carried out using the MEDLINE/PubMed, EMBASE, Scopus databases, and grey literature. The risk of bias was available in all papers included. RESULTS: A total of 2,830 articles were initially retrieved with 54 remaining for data extraction, resulting in 2,937 cases. This comprised forty-five case series' and nine cohort studies. These tumors were slightly more prevalent in females (57.4%). The patients' age ranged from 0.3 to 19 years old, with a mean age of 13.3 years. Parotid was the most affected site (81.9%), and 99.2% of cases clinically exhibited a swelling. Presence of pain/tenderness was reported in 13.5% of the cases, with an average duration of 12.6 months for the appearance of symptoms. Most of the reported cases were malignant tumors (75.4%), with mucoepidermoid carcinoma the most common tumor of all tumors (44.8%), followed by pleomorphic adenoma (24.1%). Surgery alone was the leading treatment choice in 74.9% cases, and the 5-year overall survival rate of patients was 93.1%. Patients with symptoms (P = .001), local recurrence (P < .001), metastasis (P < .001), and those not undergoing surgery or surgery combined with radiotherapy (P < .001) showed lower survival rates. CONCLUSION: The pediatric patients present a high frequency of malignant salivary neoplasms and a high overall survival rate.

Prognostic biomarkers for malignant transformation of oral potentially malignant disorders: a scoping review protocol.

OBJECTIVE: This scoping review aims to identify and systematically map the available evidence concerning the prognostic biomarkers for malignant transformation of oral potentially malignant disorders (OPMDs), and to identify and analyze possible knowledge gaps in this field of literature. INTRODUCTION: It is hypothesized that diagnosis and treatment of oral cancer in its early stages may be the key to improving the prognosis and reducing treatment-related consequences. Oral potentially malignant disorders represent tissue alterations with a higher risk of malignant transformation compared to the normal mucosa. Therefore, the study of prognostic biomarkers for OPMD could represent new diagnosis and therapeutic targets and, consequently, contribute to the reduction of oral cancer burden worldwide. INCLUSION CRITERIA: Longitudinal studies investigating prognostic biomarkers regarding the malignant transformation of OPMD will be included. The initial OPMD diagnosis and the malignant transformation must have been confirmed by histopathological analysis. To achieve minimal heterogeneity, studies that assess biomarkers in other locations (blood, plasma or others) will be excluded. METHODS: Five electronic databases and three grey literature databases will be consulted. No restrictions regarding publication date will be applied. Only studies published in the Latin (Roman) alphabet, which comprises most of the European languages, will be included. Study selection will be performed by two authors in a two-phase process; if any disagreement arises, a third author will be consulted to make a final decision. Data extraction will be performed by two authors using a standardized extraction tool. The results will be described in details accordantly with the aims of this scoping review.

Effects of dual blockade in heart failure and renal dysfunction: Systematic review and meta-analysis.

OBJECTIVE: The effect of dual renin-angiotensin system (RAS) inhibition in heart failure (HF) is still controversial. Systematic reviews have shown that dual RAS blockade may reduce mortality and hospitalizations, yet it has been associated with the increased risk of renal dysfunction (RD). Surprisingly, although RD in patients with HF is frequent, the effect of combining RAS inhibitors in HF patients with RD has never been studied in a meta-analysis. METHODS: A systematic review and meta-analysis of randomized clinical trials involving HF patients with RD who received dual blockade analyzing death, cardiovascular (CV) death or HF hospitalization, and adverse events. RESULTS: Out of 2258 screened articles, 12 studies were included (34,131 patients). Compared with monotherapy, dual RAS inhibition reduced hazard ratio of death to 0.94 (p=0.07) and significantly reduced CV death or HF hospitalization to 0.89 (p=0.0006) in all individuals, and to 0.86 (p=0.005) in patients with RD and to 0.91 (p=0.04) without RD. Nevertheless, dual RAS blockade significantly increased the risk of renal impairment (40%), hyperkalemia (44%), and hypotension (42%), although discontinuation of treatment occurs only in 3.68% versus 2.19% (p=0.00001). CONCLUSIONS: Dual RAS inhibition therapy reduces the risk of CV death or HF hospitalization. However, cautions monitoring for specific adverse events may be warranted.

Association between sleep bruxism and anxiety symptoms in adults: A systematic review.

BACKGROUND: The purpose of this systematic review was to evaluate the association between sleep bruxism (SB) and anxiety symptoms in adults. METHODS: A systematic review was performed and studies assessing SB by means of questionnaires, clinical examination and/or polysomnography (PSG), and validated questionnaires to assess anxiety, were included. Search strategies were developed for seven main electronic databases. Risk of bias was assessed using the Joanna Briggs Institute Critical Appraisal Checklist for Analytical Cross-Sectional Studies, and confidence in cumulative evidence was evaluated using the Grading of Recommendations Assessment, Development and Evaluation criteria. RESULTS: Eight cross-sectional studies were included, of which five were judged with low and three with moderate risk of bias. No association with SB was observed in three studies that investigated generic levels of anxiety, while other two papers that evaluated generic anxiety levels through the State-Trait Anxiety Inventory (STAI) found a positive association with probable and definite SB in both STAI-1 and STAI-2 subscales. Only one study evaluated dental anxiety in particular and an association with probable SB was observed regarding very anxious or extremely anxious scores. Two studies assessed specific symptoms of anxiety using the panic-agoraphobic spectra evaluation (PAS-SR) questionnaire. Significantly higher PAS-SR total scores were observed in both studies with regard to SB. No study with definitive assessment of SB was identified. CONCLUSION: Current literature is controversial regarding an association between SB and generic symptoms of anxiety in adults. It seems that some specific symptoms of the anxiety disorders spectrum might be associated with probable SB.

Prevalence of oral mucosal disorders during pregnancy: A systematic review and meta-analysis.

OBJECTIVE: To assess the prevalence of oral mucosal disorders during pregnancy. METHODS: Observational studies were selected by two reviewers in a two-phase process. Search strategies were applied at CINAHL, LILACS, LIVIVO, PubMed, Scopus, Web of Science, Google Scholar, OpenGrey, and ProQuest. The risk of bias was assessed using the Joanna Briggs Institute's Critical Appraisal Checklist for Studies Reporting Prevalence Data. Synthesis of results was calculated by the software R Statistics version 3.5.1 (The R Foundation, Vienna, Austria). Confidence in cumulative evidence was assessed by using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) criteria. RESULTS: Fifteen studies met the eligibility criteria and were selected for qualitative synthesis and meta-analysis, of which 5935 participants were enrolled. The overall prevalence of oral mucosal disorders was 11.8%. Gingival hyperplasia (17.1%), morsicatio buccarum (10%), oral candidiasis (4.4%), pyogenic granuloma (3%), and benign migratory glossitis (2.8%) were the most prevalent lesions. The overall risk of bias was considered moderate, and the quality of evidence was very low. CONCLUSION: Disorders of the oral mucosa were present in approximately 1 out of 10 pregnant women. Gingival hyperplasia was the most prevalent lesion. Further studies should apply homogeneous methodology to improve the quality of evidence.

Oropharynx HPV status and its relation to HIV infection.

BACKGROUND: The number of oropharyngeal lesions caused by HPV (Human papillomavirus) has been increasing worldwide in the past years. In spite of the clinical relevance of HPV infection in the anogenital tract of HIV-positive patients, the relevance of oropharynx HPV infection in these patients is not clear. The aim of the present study was to detect HPV infection, and clinical and cytological changes in the oropharynx of HIV-positive patients. METHODS: Samples collected from the oropharynx of 100 HIV-positive patients were subjected to hybrid capture (HC), conventional and liquid-based cytology. Clinical data were also collected to investigate the relation with HPV status. RESULTS: High and low-risk types of HPV were present in 8% and 16.7% of the total sample. The mean ± sd (maximum-minimum) of the relative ratio light unit (RLU)/cutoff (CO) was 2.94 ± 2.58 (1.09-7.87) and 1.61 ± 0.65 (1.07-2.8) for high- and low-risk-HPV, respectively. By cytology, dysplasia was not detected, but atypical squamous cells of undetermined significance (ASC-US) were diagnosed in two samples. No clinical change, suggestive of dysplasia/cancer, was detected. CONCLUSION: Our study was able to detect and characterize HPV infection by hybrid capture, which may represent a good tool for screening and follow-up of HPV in the studied population. The frequency and viral load of HPV were low. Neither clinical nor cytological changes suggestive of dysplasia/neoplasia were observed in oropharynx of HIV-positive patients.

Evaluation of immunohistochemical expression of p16 and presence of human papillomavirus in oral and oropharyngeal carcinoma.

Carcinogenesis concerns several changes that eventually result in the inactivation of tumor suppressor genes and activation of protooncogenes, leading to loss of cell cycle control. Inactivation of p16 seems to be an early event in this process and occurs in approximately 80% of squamous cell carcinoma cases. The aims of this study were to evaluate the immunohistochemical expression of p16 protein in oral and oropharyngeal squamous cell carcinoma cases, with both the tumoral area itself and its surgical margin being analyzed (dysplastic areas and histologically normal epithelium adjacent to carcinoma), and to verify the presence of human papillomavirus (HPV) and its relation to p16 expression. Paraffin-embedded biopsy tissues from 26 patients, 13 with oral squamous cell carcinoma and 13 with oropharyngeal squamous cell carcinoma, comprised the analyzed samples. To detect HPV, a nested polymerase chain reaction test using PGMY 09/11 and GP5*/GP6* primers and visualization of the product on a 2% agarose gel was performed. Demographic data were obtained from medical records. The results showed low expression of p16 in the tumor area (38.46%), compared with surgical margins in the histologically normal epithelium (84.6%) and dysplastic areas (57.7%). These findings indicate the inactivation of p16 in the process of malignant transformation. The association described in the literature between expression of p16 and presence of HPV could not be verified in this study, because none of the cases was HPV positive.

Oral manifestations of hyperoxaluria.

Primary hyperoxaluria is a rare, inherited autosomal recessive disease caused by defects in the metabolism of glyoxylate. Oral manifestations of hyperoxaluria are rare. However, bone and tooth resorption may be the result of chronic inflammation and the presence of osteoclastic cells surrounding the oxalate crystal deposit. A deposit of calcium oxalate in the periodontium was identified in a patient with end-stage renal disease. Dental radiographs indicated bone loss and external tooth resorption. Radiolucent image in the inferior incisor region was observed and removed. The tissue showed granulomatous inflammation with foreign body reaction and associated crystalline deposits. When viewed in polarized light, these deposits are green and presented a birefringent aspect, which were interpreted as calcium oxalate crystals compatible with oxaluria. Oral manifestations of hyperoxaluria are of particular interest because of the unusual location of the oxalate crystal deposition, resulting in aggressive tooth resorption and alveolar bone loss, which may be misdiagnosed.

Ressonância magnética no diagnóstico do câncer de boca: revisão da literatura e relato de caso / MRI in the diagnosis of mouth cancer: review and case report

OBJETIVO: Revisar a literatura concernente à utilização da ressonância nuclear magnética no estadiamento do câncer de boca e apresentar caso de neoplasia maligna onde a RNM contribuiu para a detecção da lesão em tecidos moles. RESULTADO E DISCUSSÃO: A RNM é a ferramenta de imagem que evolui com maior rapidez em diagnóstico na área de saúde. Suas vantagens principais são a alta resolução dos tecidos moles e ausência de risco biológico aos pacientes. Com estas qualidades, pode ser usada para detalhar a anatomia, permitindo melhor estadiamento das lesões no câncer bucal, contribuindo igualmente para o diagnóstico precoce de possíveis recidivas. No caso apresentado(neoplasia maligna de pequeno tamanho), a RNM contribuiu para a detecção da lesão em tecidos moles, na extensão da lesão e no planejamento cirúrgico.

OBJECTIVE: To review the literature about cancer staging by using magnetic resonance image (MRI) and to present a case to illustrate the utility of this image diagnosis tool. RESULTS AND DISCUSSION: MRI is the fastest evolving imaging tool for diagnosis in health area. Its main advantages include a high detail resolution soft tissue and no biological risks to patients. Thus, it can be used to evaluate the detailed anatomy of structures, allowing better staging for treatment of patients with oral cavity cancer as well as better assessment of possible post-surgical treatment and/or radiotherapy changes. Early detection of relapses is also a key advantage, which might lead to appropriate monitoring, and protocols that could greatly improve patients’welfare. The present case study illustrates the difference between the CT scan and MRI in the analysis of a small lesion, where CT scan yielded no information on clinical staging while MRI was decisive in the soft tissue injury view, extent of lesion and adequate surgical planning.

Periostite proliferativa associada a dens in dente

Proliferative periostitis is a disease characterized for successive deposition of layers of subperiosteal bone as a response reaction to a chronic inflammatory stimulation. The affected periosteum forms several rows of reactive bone that are parallel and expand the surface of the altered bone. Dens in dente is a developmental malformation resulting from invagination of the crown before calcification has occurred. They are usually diagnosed upon routine clinical and radiographic examination. An unusual case report of a mandibular dens in dente causing proliferative periostitis is presented. The source of infection was related to dens in dente in mandibular left second premolar's crown, which had apparently communication with periodontal tissues. It was successfully treated by surgical therapy with antibiotic duringthe treatment. After the extraction of the affected tooth, radiographic follow-up showed the decrease of proliferative periostitis, and remodelation of the cortical bone.

A periostite proliferativa é uma doença caracterizada por sucessivas deposições de camadas de osso subperióstica como resposta a um estímulo crônico inflamatório. O periósteo afetado forma sucessivas camadas de osso reacional paralelas entre si e expandem a superfície óssea nesse local. Dens in dente é uma alteração do desenvolvimento resultante de invaginação de esmalte para a dentina antes de sua calcificação ocorrer. Usualmente são diagnosticadas em exames clínicos-radiográficos de rotina. Um relato de caso clínico raro é apresentado sobre dens in dente na coroa do segundo pré-molar inferior causando periostite proliferativa. A fonte de infecção foi o dens in dente que tinha comunicação do meio bucal com a área do periodonto. Foi realizada a extração do dente anômalo associado com uso de antibióticos. As radiografias de controle mostraram diminuição da periostite proliferativa como remodelamento do osso cortical.

Seqüelas dentomaxilofaciais em crianças submetida a tratamento multimodal para rabdomiossarcoma / Dentomaxillofacial sequelae in a Child Reated for Rhabdomyosarcoma

O rabdomiosarcoma é o sarcoma de tecidos moles mais comum em crianças e adolescentes. A multimodalidade terapêutica para tumores de cabeça e pescoço, embora eficaz, pode resultar em uma variedade de complicações orais, com efeito significativo sobre o crescimento esquelético maxilomandibular e sobre o desenvolvimento dentário.Neste relato de caso, discutem-se as principais anormalidades tardias encontradas em um sobrevivente pediátrico que teve o tumor, o qual foi irradiado em estádio precoce do desenvolvimento dental. As anormalidades dentomaxilofaciais encontradas incluíram defeitos de esmalte, encurtamento radicular, microdontia, agenesia dentária, mobilidade dentária, micrognatia e assimetria facial. As morbidades cosméticas e funcionais encontradas exigem acompanhamento em longo prazo para melhorar a qualidade de vida da criança após o tratamento da lesão.

Rhabdomyosarcoma is the most common soft tissue sarcoma in children and adolescents. Multi-modality therapy for tumors in the head and neck region may result in a variety of oral complications, with a significant effect on maxillofacial skeletal growth and dental development. This article reports on major oral abnormalities in one long-term survivor of paediatric head and neck rhabdomyosarcoma who had irradiation at an early stage of their teeth’s development. Dentomaxillofacial abnormalities found included enamel defects, disturbance in the root development, microdontia, tooth agenesis, severe dental mobility, micrognatia and facial asymmetry. In addiction, the cosmetic and functional morbidity require follow-up over time to improve patients’ quality of life in survivors of oncologic treatment.

Expressão imunoistoquímica da ciclina D1 e do p16 em carcinoma epidermóide de boca: correlação com sistema TNM e localização / Cyclin D1 and p16 immunohistochemical expression in oral squamous cell carcinoma: correlation with TNM classification and location

Objetivo: Avaliar a expressão imunoistoquímica da ciclina D1 e do p16 (proteínas envolvidas nas vias de proliferação celular e utilizadas para determinar o prognóstico de neoplasias malignas) em carcinoma epidermóide de boca.Correlacionar a imunomarcação com o sistema TNM (Tamanho do tumor, presença de linfonodo metastático e metástase à distância) e com sua localização anatômica. Métodos: Trinta e quatro (34) blocos de parafina contendo fragmentos de biópsia incisional de carcinomas epidermóides bucais primários foram obtidos no Hospital Araújo Jorge da Associação de Combate ao Câncer em Goiás. Os dados dos pacientes quanto à localização anatômica eo Sistema TNM foram coletados dos prontuários. A expressão das proteínas ciclina D1 e p16 foi verificada através da técnica imunoistoquímica utilizando a Streptoavidina-Biotina no Laboratório de Patologia Bucal da Faculdade de Odontologia da Universidade de São Paulo (FOUSP). Resultados e Conclusões: Os resultados não revelaram diferença estatisticamente significativa entre o número médio de núcleos positivos para a ciclina D1 e os dados clínicos dos pacientes. Porém, uma menor porcentagem de marcação nos carcinomas de lábio inferior e menor expressão nos tumores classificados clinicamente como T1 foi encontrada. Não houve diferença estatisticamente significativa entre o número médio de núcleos p16 positivos e os dados clínicos dos pacientes com carcinoma epidermóide de boca. Pode-se sugerir que houve um acúmulo nuclear de p16, mas este resultado não tem significância no prognóstico. Entretanto, os resultados da ciclina D1 não mostraram que ela é um marcador absoluto de prognóstico, mas sugerem que o aumento do nível de ciclina D1 contribui junto com outros oncogenes no processo de progressão tumoral.

Relação entre o tratamento ortodôntico e o diagnóstico do cisto ósseo traumático / Relationship between orthodontic treatment and the diagnosis of traumatic bone cyst

Uma pesquisa sobre o cisto ósseo traumático foi realizada com o objetivo de estudar a prevalência deste cisto en pacientes tratados ortodonticamente e discutir sua possível relação etiopatogênica. O material constituiu de duas amostras. A amostra número 1 foi composta por 28 casos de cisto ósseo traumático e a amostra número 2 por 8 casos de cisto ósseo traumático encontrados entre 956 pacientes com tratamento ortodôntico concluído. Os resultados permitiram verificar que: a maioria dos pacientes estava na 2ª década de vida; 69,23 por cento dos pacientes da amostra 1 apresentavam alguma relação com o tratamento ortodôntico e 30,77 por cento história de trauma. Os pacientes da amostra 2 mostraram alta prevalência de cisto ósseo traumático, porém 50 por cento dos casos foram detectados na documentação ortodôntica inicial. Assim pode se concluir que o maior acesso da população ao tratamento odontológico especializado permite a detecção de lesões, até então, consideradas raras e que o ortodontista desempenha um importante papel no diagnóstico do cisto ósseo traumático

Expressäo imuno-histoquímica da ciclina d1 e do p16 em carcinoma epidermóide de boca: correlaçäo clínico-patológica / Cyclin d1 and p16 immunohistochemical expression in oral squamous cell carcinoma: clinicopathological correlation

O câncer é uma doença causada por alteraçöes nos mecanismos de controle do ciclo de divisäo e proliferaçäo celular. Vários pesquisadores têm utilizado a avaliaçäo da expressäo imuno-histoquímica de proteínas envolvidas nas vias de proliferaçäo celular para determinar o prognóstico de tumores malignos. Entre as proteínas que estäo alteradas nas células neoplásicas destacam-se algumas que säo produtos de oncogenes e de genes supressores de tumor e que estäo diretamente relacionadas com o controle do ciclo celular como, a ciclina D1 e o p16, respectivamente. Frente a estas inferências, propôs-se avaliar a expressäo imuno-histoquímica da ciclina D1 e do p16 em 34 carcinomas epidermóides de boca e correlacionar a imunomarcaçäo com os seguintes dados clínicos dos pacientes: sexo, idade, raça, tabagismo, etilismo, hereditariedade, classificaçäo clínica TNM, localizaçäo, recidiva e sobrevida dos pacientes, bem como analisar comparativamente a expressäo imuno-histoquímica da ciclina D1 com a do p16. Os resultados revelaram positividade da ciclina D1 em 85,3 por cento dos carcinomas epidermóides de boca estudados, com uma média de células imunomarcadas de 39,04 por cento. O p16 foi positivo em 79,4 por cento, obtendo-se marcaçäo numa média de 29,37 por cento das células dos carcinomas epidermóides de boca analisados. Näo se observou diferença estatisticamente significativa entre o número médio de núcleos positivos para a ciclina D1 e as informaçöes clínicas dos pacientes com carcinoma epidermóide de boca. Porém, três dados em relaçäo a ciclina D1 apresentaram relevância; 1- menor porcentagem de marcaçäo nos carcinomas de lábio inferior; 2- menor expressäo nos tumores classificados clinicamente como T1 e; 3- menor sobrevida nos carcinomas positivos e naqueles com mais de 50 por cento de células marcadas. Näo houve diferença estatisticamente significativa entre o número médio de núcleos p16 positivos e os dados clínicos dos pacientes com carcinoma epidermóide de boca. A análise comparativa da expressão imuno-histoquímica da ciclina D1 com a do p16 não mostrou correlaçäo